Revealing the Intricate Links Between Metabolism and Reproduction

Mar 6, 2025 | Life Sciences & Biology, Medical & Health Sciences

Article written by Luisa Postlethwaite, MPharm

The brain plays a vital role in controlling reproductive functions. It helps to maintain a delicate balance of hormones, all of which can be affected by the metabolism. Investigating the impact of the metabolism on reproductive development and function is critical to a better understanding of health and diseases. Professor Carol Fuzeti Elias and Dr Cristina Sáenz de Miera Patín from the University of Michigan in the USA, carry out groundbreaking research in neuroscience, exploring the molecular and neural mechanisms at play.

Nutrition Versus Reproduction

Nutrition and reproduction are closely linked. The process of reproduction has a high energy demand and, as such, can be significantly affected by the nutritional status of the individual. When nutrition is poor (for example, due to the scarcity of food), fertility is suppressed, conserving energy for critical functions. On the flip side, excess fatty tissues in the body can negatively affect ovulation, increase the risks of pregnancy complications, and kick-start puberty at a younger age. This metabolic aspect of reproductive function is coordinated by communications between a part of the brain called the hypothalamus, the pituitary gland, and the gonads, which are the ovaries in females and testes in males. This communication loop is called the hypothalamo–pituitary–gonadal (HPG) axis.

Dr Cristina Sáenz de Miera is based in the Department of Molecular and Integrative Physiology along with Dr Carol Elias, who also works in the Department of Obstetrics and Gynecology at the University of Michigan. They explain that the sites of action and mechanisms involved in the nutritional regulation of the HPG axis are not fully understood. Their research aims to determine the neural and molecular mechanisms by which metabolic imbalances can disrupt reproductive physiology.

Essential Metabolic Hormone: Leptin

Dr Elias and Dr Sáenz de Miera use genetically modified mouse models and molecular biology tools to carry out their important research. They highlight the crucial metabolic signalling hormone called leptin, which acts on the brain to regulate reproductive processes. Both mice and humans with problems producing leptin (or the receptor on the cells that it communicates with) are infertile and do not go through puberty. Previous research with genetically modified mice lacking the leptin receptor (Lepr) gene showed that they, in fact, regained their fertility when this gene was restored in their neurons.

The team adds that leptin certainly impacts the HPG axis indirectly. They explain that certain types of neurons, critical for reproduction, called gonadotropin-releasing hormone or GnRH neurons, do not feature Lepr. However, they do receive communications directly from neurons that do, highlighting that the exact neural circuitry is not currently known. The enigma continues to grow when looking more closely at the hypothalamus with its specialised features and functions.

Mysteries of the Ventral Premammillary Nucleus

The colleagues explain that the ventral premammillary nucleus (PMv) is a part of the hypothalamus that has often been overlooked in research. It is a glutamatergic nucleus, releasing the vital neurotransmitter (a molecule used for communication between neurons) called glutamate. Additionally, it is rich in neurons which feature LepR. Studies in rats with lesions on the PMv show disrupted hormone (oestrous) cycles and a reduced ability of leptin to boost reproductive hormones, such as the luteinising hormone. They also highlight that restoring LepR, specifically in the PMv of a mouse that has no LepR, rescues fertility and puberty. Neurons responsive to leptin in the PMv also make contact with neurons important to the regulation of the reproductive function, e.g., the GnRH neurons, among others. However, with the complex nature of the interactions of these hormones, neurotransmitters, and receptors, various inconsistencies have become apparent over the years of research.

Dr Elias and Dr Sáenz de Miera are attempting to unravel the mysteries of this system. In a recent publication, they aimed to determine the role of glutamate signalling from leptin-responsive PMv neurons on puberty and fertility.

Chemogenetics and DREADDS

Chemogenetics involves using molecules which have been engineered to activate or inhibit neurons. For the first part of their recent study, they used chemogenetics to work out if stimulation of PMv neurons induced the release of luteinising hormone in adult female mice during the dioestrous part of their cycle. This is the quiet period between the ovulatory days when the mice have low reproductive hormones.

They used the chemogenetic system ‘designer receptor exclusively activated by designer drugs’ – DREADDs – in genetically altered mice. This is a type of artificially engineered receptor that is only activated by particular substances, which can then be used to investigate the activity of neurons. Mice expressing the DREADDs receptor in the PMv Lepr neurons were treated with the activating drug, and blood samples were taken from the mice before and for one hour after the drug administration to determine hormone level changes. The colleagues reported increased luteinising hormone levels due to the activation of PMv neurons, plus levels were correlated to the number of neurons activated in the PMv.

Puberty, the Brain, and Beyond

Dr Elias and Dr Sáenz de Miera next used the genetically altered, or transgenic mice, to determine if lack of glutamate neurotransmission in Lepr neurons negatively affects puberty and normal reproductive functions. By removing proteins responsible for transporting glutamate to the nerve terminals, specifically in neurons that have Lepr, they found that the mice showed a delay in puberty, disruption to their oestrous cycle and luteinising hormone secretion, and an accumulation of gonadotropin-releasing hormone in the brain. These findings suggested that the mice that do not secrete glutamate in Lepr neurons have a defect in the release of GnRH, leading to deficits in reproductive function.

The team proceeded to deduce if the neurotransmitter glutamate is required for the actions of leptin in the PMv that lead to pubertal development. They used another set of genetically modified mouse models with a global lack of Lepr and deletion of glutamate transporters, specifically in PMv neurons. As they showed before, they found that restoration of Lepr in PMv neurons of obese and infertile mice restores puberty and fertility in the mice with intact glutamate neurotransmission. However, when these mice’s PMv neurons had deficient glutamate neurotransmission (due to the specific deletion of glutamate transporters) – they saw no signs of puberty or rescued fertility. The team reported that their overall findings indicate that glutamate neurotransmission from LepR neurons in the PMV is necessary for leptin action in puberty and fertility. Their findings, which are supported by high-quality, solid data, will be of great significance for research on obesity and diabetes and their deleterious effects on fertility and pregnancy.

SHARE

DOWNLOAD E-BOOK

REFERENCE

https://doi.org/10.33548/SCIENTIA1239

MEET THE RESEARCHER


Professor Carol Fuzeti Elias
Department of Molecular and Integrative Physiology, and Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, USA

Professor Carol Fuzeti Elias completed her MS in Neuroanatomy and her PhD in Neuroscience and Behaviour at the University of São Paulo, Brazil. She underwent postdoctoral training in Neurology and Neuroendocrinology at Harvard Medical School’s Beth Israel Deaconess Medical Centre in the USA. Over her well-published career, she has held positions in the Institute of Biomedical Sciences at the University of São Paulo, and the Division of Hypothalamic Research at UT Southwestern Medical Centre in Dallas, USA. She is currently a professor in the Department of Molecular and Integrative Physiology, and the Department of Obstetrics and Gynecology, at the University of Michigan in the USA. She is also the Director of the Mouse Metabolic Phenotyping Center and the Neuroscience Graduate Program. In 2020, she was elected a fellow of the American Academy for the Advancement of Sciences and is a member of the Latin American Academy of Sciences. Her main research interests are in neuroendocrinology, metabolism, and reproductive physiology.

CONTACT

E: cfelias@umich.edu

W: https://medschool.umich.edu/profile/4727/carol-elias

LinkedIn: https://www.linkedin.com/in/carol-elias-b7236428b/


Dr Cristina Sáenz de Miera Patín
Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, USA

Dr Cristina Sáenz de Miera Patín obtained her BSc in Biology at the Autonomous University of Madrid in Spain. She also completed an Erasmus Exchange Program with the University of Manchester, UK. In 2014, she obtained her joint PhD in Integrative Physiology-Neurosciences from the University of Strasbourg, France, and the University of Aberdeen, UK. She underwent postgraduate training in the Institute of Cellular and Integrative Neuroscience at the University of Strasbourg, the Department of Molecular, Cellular and Developmental Biology and also the Department of Molecular and Integrative Physiology at the University of Michigan, where she holds her current position of Research Investigator. In 2024, she received the Bishr Omary Physiology Research Investigator Award from the University of Michigan. She is a member of the American Physiological Society and the Panamerican Neuroendocrine Society. Her research interests are in the development and environmental regulation of neuroendocrine systems, and the central control of metabolism and reproduction.

 

CONTACT

E: csaenzde@umich.edu

W: https://medschool.umich.edu/profile/7543/cristina-saenz-de-miera-patin

ResearchGate: https://www.researchgate.net/profile/Cristina-Saenz-De-Miera

LinkedIn: https://www.linkedin.com/in/cristina-s%C3%A1enz-de-miera-pat%C3%ADn-769849298/

KEY COLLABORATORS

University of Michigan (Martin Myers, Suzanne Moenter, David Olson, Anuska Andjelkovic-Zochowska, Alison Affinati, Christian Burgess)

University of São Paulo (Jose Donato Jr, Renata Frazao, Jackson Bittencourt)

Stockholm University (Christian Broberger)

FUNDING

National Institute of Child Health and Human Development (NICHD)

National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)

Michigan Nutrition and Obesity Research Center (MNORC)

FURTHER READING

C Sáenz de Miera, N Bellefontaine, SJ Allen, et al., Glutamate neurotransmission from leptin receptor cells is required for typical puberty and reproductive function in female mice, eLife, 2024, 13:RP93204, DOI: https://doi.org/10.7554/eLife.93204

REPUBLISH OUR ARTICLES

We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more

Creative Commons Licence (CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

SUBSCRIBE NOW


Follow Us

MORE ARTICLES YOU MAY LIKE

Assoc Prof. Nicholas Brown | Rethinking Prostate Care: A New Frontier in Treating Benign Prostatic Hyperplasia

Assoc Prof. Nicholas Brown | Rethinking Prostate Care: A New Frontier in Treating Benign Prostatic Hyperplasia

For millions of men, ageing brings with it a set of frustrating and often disruptive urinary symptoms. These symptoms, caused by benign prostatic hyperplasia, or BPH, can affect sleep, confidence, and overall quality of life. Traditionally, treatment follows a familiar path. Patients begin with medications, often for years, and may eventually progress to surgery if symptoms worsen. Yet this pathway is not without its drawbacks. Medications can cause side effects, while surgery carries risks and recovery time. In recent years, a minimally invasive interventional radiology procedure called prostate artery embolisation, or PAE, has begun to challenge this traditional model. At the forefront of this shift is a collaborative research group, led by Dr. Nicholas Brown of the University of Queensland, whose series of P-EASY studies has explored whether PAE could transform how BPH is treated, particularly at earlier stages.

Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach

Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach

Recurrent Aphthous Stomatitis (RAS) is an oral condition characterized by one or several painful mucosal ulcers. RAS affects a large proportion of the population and has a point prevalence of approximately 2–3%, daily. The etiology remains unknown, and there is currently no curative treatment. Most patients experience recurring episodes over time, with each episode typically lasting up to a week. Here, we describe the development of a mucoadhesive patch which, when applied over a RAS ulcer, provides rapid pain relief. The patch is easy for patients to apply when symptoms begin and has the potential to be used as an over-the-counter product. The development of the Mucocort mucoadhesive patch is an example of a Close-to-Market innovation strategy that embraces simplicity within a complex healthcare system. By simplifying the product concept, the team has reduced the number of regulatory steps required before market approval. This MedTech/Pharma innovation model, known as the “4R” framework – Re-purposing, Re-formulation, Re-positioning, and Re-patenting – has guided the program from concept to commercialization. In addition to the biodegradable mucoadhesive patch developed for RAS ulcers, the team is extending the innovation concept to a mucoadhesive gel formulation for the prevention and treatment of chemotherapy-induced mucositis. This gel-based program is being commercialized separately through MucoShield.

The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care

The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care

Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease headon. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.

Ms. Aikaterini Dritsoula | Looking Beyond Snoring: How Hidden Airway Problems Shape Children’s Sleep

Ms. Aikaterini Dritsoula | Looking Beyond Snoring: How Hidden Airway Problems Shape Children’s Sleep

For many parents, a child’s snoring may seem harmless, even endearing. Yet in some cases, it signals something more serious. Obstructive sleep apnoea is a condition in which a child’s breathing is repeatedly disrupted during sleep. These interruptions can affect growth, behaviour, and learning. Children with this condition may toss and turn at night, struggle to concentrate during the day, or show signs of hyperactivity and fatigue. Traditionally, enlarged tonsils and adenoids have been seen as the main culprits. Surgery to remove them has long been considered the standard treatment. However, research led by Consultant ENT Surgeon Ms. Aikaterini Dritsoula of The Leeds Teaching Hospitals NHS Trust invites us to look deeper. Her work suggests that the story is often more complex, especially in very young children.